{"id":"W2609464715","doi":"10.1186/s13048-017-0319-2","title":"Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells","year":2017,"lang":"en","type":"article","venue":"Journal of Ovarian Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Carboplatin; Dasatinib; Gefitinib; Crizotinib; Ovarian cancer; Medicine; Cancer research; Hepatocyte Growth Factor Receptor; Epidermal growth factor receptor; Internal medicine; Cancer; Oncology; Pharmacology; C-Met; Lung cancer; Tyrosine kinase; Receptor; Chemotherapy; Cisplatin; Hepatocyte growth factor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001959193,0.0002793964,0.0004157844,0.0004439328,0.0009823873,0.0004225711,0.0008146729,0.0002951607,0.00004117901],"category_scores_gemma":[0.0005172215,0.0002354078,0.0001162464,0.0001986692,0.0005917132,0.00006945528,0.0002888543,0.0009709051,0.000005146495],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001012912,"about_ca_system_score_gemma":0.001298646,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002776735,"about_ca_topic_score_gemma":0.0001746151,"domain_scores_codex":[0.9966371,0.0004106285,0.0005359481,0.0005053929,0.001222517,0.0006884288],"domain_scores_gemma":[0.9964458,0.0001217967,0.0006218773,0.0006636768,0.001775257,0.0003715524],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004062796,0.0001840243,0.02037195,0.0001539747,0.0001312686,0.0001403206,0.0001611455,0.00003060834,0.9764023,0.00007513318,0.00109398,0.0008489634],"study_design_scores_gemma":[0.004173688,0.001573278,0.1632599,0.0004271769,0.0000139985,0.00002096857,0.0001507693,0.00004814262,0.8298326,0.00006320558,0.0001880844,0.0002481923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963849,0.0001214445,0.000673106,0.0006375077,0.0001449265,0.0004732338,0.00004099891,0.000006132899,0.00151779],"genre_scores_gemma":[0.9977524,0.0002280496,0.001156557,0.00005700435,0.0004984114,0.00002348154,0.00002504816,0.00006252065,0.000196523],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1465698,"threshold_uncertainty_score":0.959965,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02991683898418688,"score_gpt":0.335500317895296,"score_spread":0.3055834789111091,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}